Midlothian, VA, United States of America

Scott Jeffrey Ackerman

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Colfax, WA (US) (2017)
  • Midlothian, VA (US) (2024)

Company Filing History:

goldMedal1 out of 12 
 
Carmax Enterprise Services, LLC
 patents
silverMedal1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2017-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Scott Ackerman: Innovator in Porcine Vaccine Development

Introduction

Scott Ackerman is a prominent inventor based in Huxley, Iowa, known for his significant contribution to veterinary medicine through the development of a vaccine aimed at protecting pigs from severe coronavirus-related diseases. With a focus on improving swine health, Ackerman’s innovations have the potential to impact animal husbandry positively.

Latest Patents

Ackerman holds a patent for a novel porcine coronavirus vaccine designed to protect pigs against diseases associated with coronavirus infections, specifically the porcine epidemic diarrhea virus (PEDV) and the porcine deltacorona virus (PDCoV). The innovative vaccine combines inactivated or killed strains of these viruses, including adjuvants and recombinant antigens, to enhance immune response and efficacy. The methods for its production and application are also outlined in his patent, addressing critical health concerns in swine populations.

Career Highlights

Throughout his career, Scott Ackerman has focused on advancements in vaccine development, particularly within the agricultural sector. His work is vital for the prevention of viral outbreaks in pig populations, which can have profound effects on the agricultural economy and food supply. This singular patent reflects his dedication to enhancing the health of livestock and his commitment to veterinary innovation.

Collaborations

Scott Ackerman has collaborated with fellow researchers Joseph Ralph Hermann and Luis Alejandro Hernandez to further explore the field of porcine health and develop effective vaccination strategies. Their collective expertise contributes to the advancement of veterinary research and supports the development of practical solutions to endemic challenges facing pig farming today.

Conclusion

In conclusion, Scott Ackerman's contributions to the field of veterinary immunology, particularly with his patented porcine coronavirus vaccine, underscore his role as an innovator dedicated to improving animal health. His collaboration with notable colleagues enhances the impact of his research and opens new avenues for advancements in swine health management. Ackerman's work is a testament to how targeted innovation can significantly benefit both livestock and the wider agricultural industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…